239 related articles for article (PubMed ID: 28870843)
1. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract][Full Text] [Related]
2. Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.
Desai TJ; Toombs JE; Minna JD; Brekken RA; Udugamasooriya DG
Oncotarget; 2016 May; 7(21):30678-90. PubMed ID: 27120792
[TBL] [Abstract][Full Text] [Related]
3. Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.
Vallabhapurapu SD; Blanco VM; Sulaiman MK; Vallabhapurapu SL; Chu Z; Franco RS; Qi X
Oncotarget; 2015 Oct; 6(33):34375-88. PubMed ID: 26462157
[TBL] [Abstract][Full Text] [Related]
4. Detection of cancer cells using SapC-DOPS nanovesicles.
Davis HW; Hussain N; Qi X
Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
[TBL] [Abstract][Full Text] [Related]
5. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
N'Guessan KF; Patel PH; Qi X
Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
[TBL] [Abstract][Full Text] [Related]
6. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
Kaynak A; Davis HW; Kogan AB; Lee JH; Narmoneva DA; Qi X
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626139
[TBL] [Abstract][Full Text] [Related]
8. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
[TBL] [Abstract][Full Text] [Related]
9. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.
Desai TJ; Udugamasooriya DG
Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795
[TBL] [Abstract][Full Text] [Related]
11. L-methionase: a therapeutic enzyme to treat malignancies.
Sharma B; Singh S; Kanwar SS
Biomed Res Int; 2014; 2014():506287. PubMed ID: 25250324
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
Wojton J; Chu Z; Mathsyaraja H; Meisen WH; Denton N; Kwon CH; Chow LM; Palascak M; Franco R; Bourdeau T; Thornton S; Ostrowski MC; Kaur B; Qi X
Mol Ther; 2013 Aug; 21(8):1517-25. PubMed ID: 23732993
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.
Blanco VM; Chu Z; Vallabhapurapu SD; Sulaiman MK; Kendler A; Rixe O; Warnick RE; Franco RS; Qi X
Oncotarget; 2014 Aug; 5(16):7105-18. PubMed ID: 25051370
[TBL] [Abstract][Full Text] [Related]
14. Targeting phosphatidylserine for Cancer therapy: prospects and challenges.
Chang W; Fa H; Xiao D; Wang J
Theranostics; 2020; 10(20):9214-9229. PubMed ID: 32802188
[TBL] [Abstract][Full Text] [Related]
15. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
[TBL] [Abstract][Full Text] [Related]
16. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
[TBL] [Abstract][Full Text] [Related]
17. Targeting phosphatidylserine in anti-cancer therapy.
Kenis H; Reutelingsperger C
Curr Pharm Des; 2009; 15(23):2719-23. PubMed ID: 19689342
[TBL] [Abstract][Full Text] [Related]
18. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes.
Callahan MK; Williamson P; Schlegel RA
Cell Death Differ; 2000 Jul; 7(7):645-53. PubMed ID: 10889509
[TBL] [Abstract][Full Text] [Related]
19. Gla-domain mediated targeting of externalized phosphatidylserine for intracellular delivery.
Hardy J; Bauzon M; Chan CKF; Makela AV; Kanada M; Schneider D; Blankenberg F; Contag CH; Hermiston T
FASEB J; 2023 Aug; 37(8):e23113. PubMed ID: 37486772
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
